BDC Laboratories Partners with Dilawri Cardiovascular Institute to Enhance Cardiovascular Device Testing

BDC Laboratories and Dilawri Cardiovascular Institute Forge a Strategic Partnership

In a move poised to reshape cardiovascular care, BDC Laboratories has joined forces with the newly established Dilawri Cardiovascular Institute (DCI). This collaboration seeks to elevate the development and validation of cardiovascular medical devices, linking cutting-edge research with real-world clinical practices. The focus of this partnership is to advance device testing and simulation in order to achieve more significant, evidence-backed outcomes for patients.

BDC Laboratories, recognized for its leadership in cardiovascular device testing, has equipped DCI with its state-of-the-art HDTi-6000 pulse duplicator. This sophisticated testing platform is designed to replicate real clinical conditions, ensuring reliability and adaptability in evaluations. As DCI embarks on its mission to foster cardiovascular innovation, the partnership aligns perfectly with the organization's goal to bridge research and practical applications across the cardiac practice continuum.

DCI's Center for Cardiovascular Translational Science will play a pivotal role in this initiative. The center aims to bridge the divide between laboratory research and bedside applications, concentrating on the evolution of medical devices that can significantly impact patient care. The partnership will allow DCI to lead innovative projects, particularly in transcatheter heart valve technologies, a crucial area in cardiac treatment.

Stephanie Sellers, PhD and Director of the Center, emphasizes the center’s commitment to creating more clinically relevant models that mirror the challenges faced by healthcare practitioners. She states, "Our objective is to empower our partners in developing exceptional medical devices. Even a minimal shift in clinical outcomes can represent a significant success."

Enhancing Clinical Outcomes through Collaboration

BDC Laboratories is invested in ensuring its testing platforms reflect the ever-changing landscape of cardiovascular care. By engaging with clinical experts, regulatory agencies, and industry leaders, the organization aims to evolve its solutions to meet emerging needs. Specifically, the collaboration intends to tackle challenges such as testing protocols for complex valve scenarios and accommodating unique anatomical conditions.

Craig Weinberg, PhD, Chief Technology Officer at BDC Laboratories, notes, "In the rapidly evolving field of cardiovascular innovations, the pace of development often surpasses regulatory guidance. Our R&D team works closely with professionals like Stephanie and her team to ensure our testing solutions remain relevant while adhering to existing standards."

BDC Laboratories is a vital player in assessing Class II and Class III medical device technologies, offering a range of services that encompass mechanical and functional evaluations suited for regulatory submissions. This partnership with DCI illustrates BDC's dedication to fostering innovation through rigorous testing models that prioritize both safety and efficacy.

About the Collaborating Institutions

BDC Laboratories provides comprehensive testing services that facilitate the regulatory path for medical device developers, supporting them from the research and development phase up until market entry. Their focus on bioprosthetic valve assessments and advanced testing equipment makes them a leader in the field.

The Dilawri Cardiovascular Institute is committed to pioneering advancements in medical technologies that transform how heart conditions are diagnosed, treated, and managed. Whether addressing the needs of patients, physicians, researchers, or industry leaders, DCI emphasizes a cohesive approach where science, technology, and compassionate care intersect.

This partnership not only enhances testing capabilities in cardiovascular technology but also reaffirms the commitment of both organizations to improving patient outcomes through sound research and clinical insight. Together, BDC Laboratories and DCI are setting a precedent for future collaborations that prioritize innovation in healthcare.